Cargando…

BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer

The Breast Cancer Test (BCT) score has been validated for its ability to predict the risk of distant metastasis in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer. This study aimed to examine the value of the BCT score for predicting the benefi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwon, Mi Jeong, Lee, Sae Byul, Han, Jinil, Lee, Jeong Eon, Lee, Jong Won, Gong, Gyungyub, Beitsch, Peter D., Nam, Seok Jin, Ahn, Sei Hyun, Nam, Byung-Ho, Shin, Young Kee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248959/ https://www.ncbi.nlm.nih.gov/pubmed/30462685 http://dx.doi.org/10.1371/journal.pone.0207155

Ejemplares similares

Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2019)

Validation of the GenesWell BCT Score in Young Asian Women With HR+/HER2− Early Breast Cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2021)

Survival Outcome of Combined GnRH Agonist and Tamoxifen Is Comparable to That of Sequential Adriamycin and Cyclophosphamide Chemotherapy Plus Tamoxifen in Premenopausal Patients with Lymph-Node–Negative, Hormone-Responsive, HER2-Negative, T1-T2 Breast Cancer
por: Sohn, Guiyun, et al.
Publicado: (2016)

Axillary Lymph Node Dissection Rates and Prognosis From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer
por: Gwark, Sungchan, et al.
Publicado: (2021)

Is the intraoperative frozen section analysis of sentinel lymph nodes necessary in clinically negative node breast cancer?
por: Jung, Sung Mi, et al.
Publicado: (2020)

MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer
por: Han, Jinil, et al.
Publicado: (2017)

Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay
por: Lee, Jun-Hee, et al.
Publicado: (2022)

Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer
por: Gwark, Sungchan, et al.
Publicado: (2021)

A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2− early breast cancer
por: Gong, Gyungyub, et al.
Publicado: (2017)

Prognosis according to clinical and pathologic lymph node status in breast cancer patients who underwent sentinel lymph node biopsy alone after neoadjuvant therapy
por: Lee, Sae Byul, et al.
Publicado: (2021)

Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer
por: Kim, Hee Jeong, et al.
Publicado: (2020)

Comparative Study between Sentinel Lymph Node Biopsy and Axillary Dissection in Patients with One or Two Lymph Node Metastases
por: Lee, Jina, et al.
Publicado: (2018)

Clinical Significance of the Axillary Arch in Sentinel Lymph Node Biopsy
por: Kil, Won Ho, et al.
Publicado: (2014)

Retraction note to: "Clinical Significance of the Axillary Arch in Sentinel Lymph Node Biopsy"
por: Kil, Won Ho, et al.
Publicado: (2015)

Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
por: Choi, Hee Jun, et al.
Publicado: (2022)

Immune repertoire and responses to neoadjuvant TCHP therapy in HER2-positive breast cancer
por: Shin, Junyoung, et al.
Publicado: (2023)

Preoperative serum HER2 extracellular domain levels in primary invasive breast cancer
por: Lee, Sae Byul, et al.
Publicado: (2014)

A Nomogram for Predicting the Oncotype DX Recurrence Score in Women with T1-3N0-1miM0 Hormone Receptor‒Positive, Human Epidermal Growth Factor 2 (HER2)‒Negative Breast Cancer
por: Lee, Sae Byul, et al.
Publicado: (2019)

Sentinel Lymph Node Biopsy Was Associated With Favorable Survival Outcomes For Patients With Clinically Node-Negative Asian Melanoma
por: Chang, John Wen-Cheng, et al.
Publicado: (2019)

Targeted exome sequencing of Korean triple-negative breast cancer reveals homozygous deletions associated with poor prognosis of adjuvant chemotherapy-treated patients
por: Jeong, Hae Min, et al.
Publicado: (2017)

Relation Between Tumor Size and Lymph Node Metastasis According to Subtypes of Breast Cancer
por: Min, Seung Ki, et al.
Publicado: (2021)

BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts
por: Lee, Joo-Yeon, et al.
Publicado: (2018)

Association between tumor (18)F-fluorodeoxyglucose metabolism and survival in women with estrogen receptor-positive, HER2-negative breast cancer
por: Chae, Sun Young, et al.
Publicado: (2022)

Interaction between body mass index and hormone-receptor status as a prognostic factor in lymph-node-positive breast cancer
por: Chung, Il Yong, et al.
Publicado: (2017)

Which Patients with Isolated Para-aortic Lymph Node Metastasis Will Truly Benefit from Extended Lymph Node Dissection for Colon Cancer?
por: Bae, Sung Uk, et al.
Publicado: (2018)

Is Sentinel Lymph Node Biopsy for Breast Cancer with Cytology-Proven Axillary Metastasis Safe? A Prospective Single-Arm Study
por: Choi, Hee Jun, et al.
Publicado: (2021)

Clinical outcomes after sentinel lymph node biopsy in clinically node-negative breast cancer patients
por: Han, Hee Ji, et al.
Publicado: (2014)

Association of Body Mass Index With 21-Gene Recurrence Score Among Women With Estrogen Receptor–Positive, ERBB2–Negative Breast Cancer
por: Lee, Janghee, et al.
Publicado: (2022)

HER2 as a potential biomarker of lymph node metastasis in undifferentiated early gastric cancer
por: Han, Sanghoon, et al.
Publicado: (2020)

Lead-Free AE Sensor Based on BZT–BCT Ceramics
por: Shin, Dong-Jin, et al.
Publicado: (2021)

Non-sentinel node metastasis prediction during surgery in breast cancer patients with one to three positive sentinel node(s) following neoadjuvant chemotherapy
por: Chun, Jung Whan, et al.
Publicado: (2023)

Lymph node status in different molecular subtype of breast cancer: triple negative tumours are more likely lymph node negative
por: Liu, Ning, et al.
Publicado: (2017)

Comparison of clinicopathological characteristics of lymph node positive and lymph node negative breast cancer
por: Hadi, Naila Irum, et al.
Publicado: (2016)

Prospective Evaluation of the Feasibility of Sentinel Lymph Node Biopsy in Breast Cancer Patients with Negative Axillary Conversion after Neoadjuvant Chemotherapy
por: Lee, Hy-De, et al.
Publicado: (2015)

Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway
por: Kim, Sangmin, et al.
Publicado: (2015)

Omitting Sentinel Lymph Node Biopsy after Neoadjuvant Systemic Therapy for Clinically Node Negative HER2 Positive and Triple Negative Breast Cancer: A Pooled Analysis
por: Alamoodi, Munaser, et al.
Publicado: (2023)

Use of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients with Axillary Node-Positive Breast Cancer in Diagnosis
por: Choi, Hee Jun, et al.
Publicado: (2018)

A functional comparison between the HER2(high)/HER3 and the HER2(low)/HER3 dimers on heregulin-β1-induced MMP-1 and MMP-9 expression in breast cancer cells
por: Kim, Sangmin, et al.
Publicado: (2012)

Patterns of Axillary Lymph Node Metastasis in Breast Cancer: A Prospective Single-Center Study
por: Choi, Hee Jun, et al.
Publicado: (2018)

What does absence of lymph node in resected specimen mean after neoadjuvant chemoradiation for rectal cancer
por: Lee, Won-Suk, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6o9tol63ub7pmpsfkpk8sklhhv